| 1 | Approve Financial Statements | For |
| 2 | Receive the Directors Report | For |
| 3 | Approve Non-Financial Statements | For |
| 4 | Discharge the Board | For |
| 5.1 | Re-appoint the Auditors, KPMG | Oppose |
| 5.2 | Appoint the Auditors PwC for Financial Year 2027 to 2029 | For |
| 6 | Approve the Engagement Dividend of EUR 0.005 per Share | For |
| 7 | Approve the Supplementary Dividend of EUR 0.427 per Share | For |
| 8 | Authorise Capital Increase for the Scrip Dividend | For |
| 9 | Authorise Capital Increase for the Second Scrip Dividend | For |
| 10.1 | Reduce Share Capital | For |
| 10.2 | Reclassifications of Reserves from Amortised Capital to Voluntary Reserves | For |
| 11 | Approve the Remuneration Report | Oppose |
| 12 | Approve 2026–2028 Share-Based LTIP | For |
| 13 | Approve Remuneration Policy | Oppose |
| 14 | Re-elect Maria Angeles Alcala Diaz - Non-Executive Director | For |
| 15 | Re-elect Isabel García Tejerina - Non-Executive Director | For |
| 16 | Re-elect Anthony L. Gardner - Vice Chair (Non Executive) | For |
| 17 | Elect Marina Freitas Gonçalves de Araújo Grossi - Non-Executive Director | For |
| 18 | Elect Pedro Azagra Blázquez - Chief Executive | For |
| 19 | Set Board Size at Fourteen Directors | For |
| 20 | Authorise Share Repurchase | Oppose |
| 21 | Formalities | For |
